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Abstract
Background: The Nuclear Factor I (one) (NFI) family of transcription/replication factors plays
essential roles in mammalian gene expression and development and in adenovirus DNA replication.
Because of its role in viral DNA replication NFI has long been suspected to function in host DNA
synthesis. Determining the requirement for NFI proteins in mammalian DNA replication is
complicated by the presence of 4 NFI genes in mice and humans. Loss of individual NFI genes in
mice cause defects in brain, lung and tooth development, but the presence of 4 homologous NFI
genes raises the issue of redundant roles for NFI genes in DNA replication. No NFI genes are
present in bacteria, fungi or plants. However single NFI genes are present in several simple animals
including Drosophila and C. elegans, making it possible to test for a requirement for NFI in
multicellular eukaryotic DNA replication and development. Here we assess the functions of the
single nfi-1 gene in C. elegans.
Results: C. elegans NFI protein (CeNFI) binds specifically to the same NFI-binding site recognized
by vertebrate NFIs. nfi-1 encodes alternatively-spliced, maternally-inherited transcripts that are
expressed at the single cell stage, during embryogenesis, and in adult muscles, neurons and gut cells.
Worms lacking nfi-1 survive but have defects in movement, pharyngeal pumping and egg-laying and
have a reduced life-span. Expression of the muscle gene Ce titin is decreased in nfi-1 mutant worms.
Conclusion: NFI gene function is not needed for survival in C. elegans and thus NFI is likely not
essential for DNA replication in multi-cellular eukaryotes. The multiple defects in motility, egg-
laying, pharyngeal pumping, and reduced lifespan indicate that NFI is important for these processes.
Reduction in Ce titin expression could affect muscle function in multiple tissues. The phenotype of
nfi-1 null worms indicates that NFI functions in multiple developmental and behavioral systems in
C. elegans, likely regulating genes that function in motility, egg-laying, pharyngeal pumping and
lifespan maintenance.
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We are studying the role of the highly conserved Nuclear
Factor I (NFI) family of site-specific DNA-binding pro-
teins in metazoan development. NFI was first identified as
a protein from human HeLa cells required for efficient
adenovirus (Ad) DNA synthesis in vitro [1]. A binding site
for NFI proteins in the Ad origin of replication is essential
for viral replication both in vitro and in vivo [1-5]. These
and other studies suggested that NFI proteins may func-
tion in the replication of host cell DNA [6,7]. However
there is no direct evidence to support or refute a role for
NFI proteins in host DNA synthesis. In contrast, many
studies have identified NFI binding sites in the promoter
and distal control regions of cellular genes, and deletion
analysis of sites shows that NFI proteins are important for
gene expression in a variety of cell types [8,9].
Four conserved NFI genes are present in vertebrates
(NFIA, NFIB, NFIC and NFIX in humans; Nfia, Nfib, Nfic
and Nfix in mice) [10-13]. Single NFI genes have been
identified in the simple metazoans Amphioxus, C. elegans,
and Drosophila [14,15], but no NFI genes are present in
fungi, Arabidopsis or any sequenced prokaryotic genome.
Thus the NFI gene family arose during early metazoan
evolution and appears to be present only in multicellular
animals. NFI proteins bind as either homo- or heterodim-
ers [16,17] to the symmetric consensus sequence
TTGGC(N5)GCCAA in duplex DNA [18,19]. NFI proteins
also bind with lower affinity to sites containing a single
TTGGC motif [20,21]. NFI homo- and heterodimers bind
to the same sites with similar affinities, making it difficult
to determine which family members play essential roles at
specific cellular promoters. In addition, the 4 NFI genes in
vertebrates are alternatively spliced [16,22] and are
expressed in specific but widely overlapping patterns dur-
ing embryogenesis and adult life [13] making it difficult
to assess the role of specific NFI genes in development.
The role of the NFI genes in development is of particular
interest because binding sites for NFI proteins have been
identified in genes expressed in virtually every tissue and
organ system of vertebrates including brain [23,24], mus-
cle [25] and other tissues. NFI proteins have also been
implicated in the control of gene expression by a number
of hormones and physiological modulators including glu-
cocorticoids [26,27], insulin [28,29], TGFβ [30,31] and
others.
To assess the roles of NFI genes in development we began
a genetic analysis of the NFI genes in mice and C. elegans.
Disruption of Nfia results in neurological defects includ-
ing agenesis of the corpus callosum, loss of midline glial
cells [32], hydrocephalus and perinatal lethality [33]. Dis-
ruption of Nfic causes defects in tooth development [34]
while loss of Nfib results in perinatal lethality due to
defects in lung maturation [35,36]. In each knockout
defects are seen in the presence of the other three verte-
brate NFI genes, suggesting that the 4 mouse NFI genes
each have essential roles in development. However the
presence of 4 NFI genes in mice has made it impossible to
test whether NFI activity per se is essential for survival.
Since C. elegans has only one NFI gene (nfi-1), it provides
an ideal system to assess the role of NFI in DNA replica-
tion and simple animal development. We show here that
C. elegans nfi-1 and its products share many properties
with their vertebrate homologs including similar DNA-
binding activity, alternative splicing and expression dur-
ing embryogenesis and in adult tissues. Loss of nfi-1
results in viable worms with multiple defects in locomo-
tion, pharyngeal pumping and egg-laying, and a short-
ened life-span. Thus, nfi-1 is non-essential for survival but
plays an important role in C. elegans physiology.
Results
Alternative splicing and promoter of the nfi-1 gene
The C. elegans nuclear factor I gene (nfi-1) was first identi-
fied by the C. elegans sequencing consortium by its
homology to mammalian NFI genes [14]. Only a single
NFI gene is present in the C. elegans genome (Fig. 1A)
while vertebrates possess 4 NFI genes. To confirm the
structure of the nfi-1 gene, we obtained cDNAs from the
Kohara and TIGR libraries and made primers within pre-
dicted exons for production of cDNAs from RNA of adult
worms and purified eggs. These cDNAs confirmed the
presence of 14 exons and showed alternative splicing of
exons 2 and 13 (Fig. 1A). The differential splicing pattern
of nfi-1 indicates that different isoforms may be expressed
in different cell types. Primary transcripts from most C.
elegans genes are trans-spliced to SL1 leader sequences and
detection of SL1-linked transcripts is frequently used to
assess the initially transcribed exons of genes [37]. We
confirmed the start site of the gene using PCR with an SL1
primer for SL1-containing transcripts and a primer in
exon 2.
DNA binding by CeNFI is indistinguishable from that of 
human NFI-C
The predicted DNA-binding domain of nfi-1 (CeNFI-
DBD) shares homology with the vertebrate NFI proteins,
however 60 of 151 residues that are completely conserved
among the 4 mouse NFI proteins are changed in CeNFI
(Fig. 1B). To assess the DNA-binding activity and specifi-
city of CeNFI, the DNA-binding domain (DBD) of CeNFI
was cloned in frame with a 6 histidine-tag, expressed in E.
coli, partially purified by nickel-affinity chromatography,
and was used for in vitro DNA binding assays. The DNA-
binding activity of CeNFI-H6 was indistinguishable from
that of the human hNFI-C220H6, with both proteins
binding the NFI-site oligo 2.6 (Fig. 2A) but not the C2
oligo containing a point mutation that prevents vertebratePage 2 of 17
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A) Alternatively spliced products of the nfi-1 gene. The nfi-1 gene is shown as a line with exons as numbered solid boxes 
and alternatively spliced exons as gray boxes. Arrows show the direction of transcription. Below the line are cDNAs from the 
Kohara and TIGR libraries; the vertical bar indicates the 5' end of the cDNA. In yK213C10 the letters a and b above exon 2 
denote that it is alternatively spliced generating 2a and 2b and the arrow on the right denote undetermined sequence in the 
cDNA. The asterisk (*) on yk42f10 denotes an alternative 3'splice acceptor site in exon 13 used in yk42f10 but not in 
CEESQ09. Below are depictions of cDNAs obtained by RT-PCR from total and polyA+ RNA of whole worms or isolated eggs 
using nfi-1 exon-specific primers (RT-PCR nfi-1 primers). Lastly we show cDNA obtained by PCR using SL1 primer and nfi-1 
exon-specific primers (RT-PCR SL1-linked products). Some of the alternatively spliced cDNAs have been described previously 
[14]. B) Comparison of CeNFI-DBD with the consensus mouse NFI DBD.The sequence of the CeNFI-DBD (top line) 
is aligned to a consensus sequence from the 4 mouse NFI-DBDs (bottom line). Gaps in the mouse consensus indicate residues 
that are not identical between the 4 mouse NFI-DBDs. The dash in the 6th aligned row indicates a single insertion in the 
CeNFI-DBD sequence needed to align it with the mouse consensus. Dark gray boxes show identical residues in CeNFI-DBD 
and mouse NFI-DBDs, light gray boxes show residues not identical but similar between CeNFI and mouse NFI-DBDs, unboxed 
residues with black letters show residues that are not similar between the CeNFI and mouse DBDs, and gray letters in the 
CeNFI-DBD above gaps in the mouse consensus indicate positions where the 4 mouse genes are not identical. 151 of 190 res-
idues are identical in all 4 mouse NFI-DBDs while 60 of these 151 residues are different in the CeNFI-DBD and 27 of these 60 
differences are non-conservative substitutions. The alignment was done in Macvector 6.5.3 using the ClustalW similarity 
matrix.Page 3 of 17
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a protein with similar DNA binding properties as CeNFI-
H6, extracts were prepared from a mixed population of
worms and tested for binding to the 2.6 and C2 sites. As
expected, proteins were detected that bound to the 2.6 but
not the C2 site, confirming the binding specificity of
CeNFI (Fig. 2B). The specificity of the native and recom-
binant CeNFI proteins was also measured by competition
of binding of the 2.6 oligo with various unlabeled oligo-
nucleotides and was indistinguishable from the specificity
of hNFI-C220-H6 (data not shown). Thus despite the dif-
ferences between CeNFI and vertebrate NFIs in conserved
residues of their DNA-binding domains, their DNA-bind-
ing activities are indistinguishable.
Expression of nfi-1 in embryo and adults
In the mouse, the 4 NFI genes are expressed in a complex
overlapping pattern during embryogenesis and in adult
tissues [13]. To assess the expression pattern of nfi-1 tran-
scripts in C. elegans, a digoxin-labeled antisense probe
from the 3' end of the nfi-1 transcript was used for in-situ
hybridization to fixed embryos and whole worms [39].
nfi-1 transcripts are present in the one-cell (not shown)
and two-cell stages (Fig. 3a) prior to the onset of zygotic
A) Specific NFI DNA-binding activity of recombinant CeNFI-H6Figure 2
A) Specific NFI DNA-binding activity of recombinant CeNFI-H6. Partially purified recombinant H6-tagged CeNFI 
(containing parts of exons 2–8) and human NFI-C220 were incubated with a duplex oligonucleotide containing an NFI binding 
site (2.6, even lanes) or an oligo with a single point mutation that abolishes NFI binding (C2, odd lanes) and analyzed on a 6.5% 
non-denaturing polyacrylamide gel. Lanes 1 and 2, crude E. coli extract (neg. control); lanes 3 and 4, ~5 ng partially purified 
CeNFI-H6; lanes 5 and 6, ~40 ng partially purified CeNFI-H6; lanes 7 and 8, ~5 ng purified human NFI-C220H6. See bottom of 
panel for sequences of oligonucleotides. B) Specific NFI DNA-binding activity in worm extracts. Nuclear extracts of a 
mixed population of C. elegans were prepared and used in a gel mobility shift assay with an oligonucleotide that contains an 
NFI-binding site (lanes 1 & 2, 2.6) or the same oligo with a single point mutation that abolishes NFI binding (lane 3, C2). Lane 1, 
no extract; Lanes 2 and 3, C. elegans extract (~10 µg). See A for sequences of oligonucleotides.Page 4 of 17
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Expression of endogenous nfi-1 mRNA in embryo and adults. N2 worms were fixed and hybridized with digoxigenin 
(DIG)-labeled antisense nfi-1 probe (from plasmid yk42f10) and bound probe was detected using alkaline phosphatase-conju-
gated anti-DIG antibodies. Panels: a, 2 cell embryo; b, 4 cell embryo; c, 24 cell embryo; d, beginning gastrulation; e, mid-gastru-
lation; f, late gastrulation; g, comma stage; h, 1.5-fold stage and i, 2-fold stage. Embryos in a-d and f-i are positive for staining. 
We are currently investigating the apparent loss of signal at mid-gastrulation (panel e). Panels j-m, antisense probe, adults with 
exposed internal organs: mature oocytes; intestine; gonadal germ cells; n-o, control sense probe, no specific staining is seen. 
Right panels k, m, o are two-fold magnifications of those on the left.Page 5 of 17
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maternally inherited. Expression continues in most cells
of the embryo throughout early and mid-embryogenesis
(Fig. 3b–d) but decreases after gastrulation and no expres-
sion is seen in L1 larvae (Fig. 3f–i and data not shown). As
expected for a maternally inherited transcript, expression
of nfi-1 reappears in the adult gonad (Fig. 3j–m). Expres-
sion of nfi-1 transcripts are also seen in the cytoplasm of
gut cells (Fig. 3j–m). No signal is seen using control sense
probes (Fig. 3n–o and data not shown). This in situ expres-
sion pattern indicates that nfi-1 could function both early
in embryogenesis and in adult worms.
Isolation of a null allele of nfi-1
To assess the role of nfi-1 in worms, we isolated a nfi-1
mutant using a reverse genetic approach based on the
insertion-excision of the transposon Tc1 [42]. Worms car-
rying an ~2 kb deletion in nfi-1 were isolated by PCR
screening and sib-selection (Fig. 4A,B). Sequence analysis
of the nfi-1 transposon excision allele (designated nfi-
1(qa524)) showed loss of the genomic region correspond-
ing to nucleotides 14754–16715 of cosmid ZK1290. This
eliminates the first 6 exons of nfi-1 including sequences
encoding the DNA-binding domain. RT-PCR shows the
absence of nfi-1 transcripts in mutant worms (Fig. 4C). A
gel mobility shift assay, using nuclear extracts prepared
from mix-stage populations of C. elegans wild type and
nfi-1 mutant worms confirmed the loss of CeNFI DNA-
binding activity in the mutant worms (Fig 4D). Thus, this
mutation in the nfi-1 gene is a null allele. The survival of
worms homozygous for the null allele shows that nfi-1 is
not essential for worm survival. The nfi-1 mutant allele
was backcrossed 12 times to the wild-type N2 strain to
remove unwanted mutations prior to assessment of the
phenotype.
Phenotype of nfi-1 mutant worms
Locomotion defect
Loss of nfi-1 results in a body movement defect (Unc,
uncoordinated). nfi-1 mutant animals are fairly active and
healthy, but are sluggish and flaccid at rest and slightly
longer and thinner than N2 worms (Fig. 5A,D). While
wild type worms usually move in straight long lines, nfi-1
mutant worms often change direction abruptly (Fig.
5B,E). The nfi-1mutant worms produce less regular tracks
on the bacterial lawn with higher amplitude, and some-
times are slightly coiled when compared to wild-type
worms (Fig. 5C,F). This phenotype is more severe in older
adults.
Egg-laying defect (Egl)
17–35% of older nfi-1 mutants have a "bag of worms"
phenotype, where the mother is unable to lay fertilized
eggs and fills with hatched progeny (Fig. 6A). Appearance
and severity of this egg-laying phenotype correlates with
the progressive locomotion defect, as young adult nfi-1
mutant worms do not bag. In young adults, serotonin
stimulated egg-laying in both the wild type and nfi-1
mutant animals to a similar extent (data not shown), indi-
cating that the postsynaptic response to serotonin is nor-
mal and the contractile apparatus for egg-laying is intact
in nfi-1 mutant worms.
Life-span reduction
The nfi-1 mutant worms have a median life span of 10.00
± 0.69 days as compared to 14.00 ± 0.76 days for wild type
worms (p < 0.001) (Fig. 6B). Mutant worms become pro-
gressively more sluggish and flaccid as they age. We are
currently investigating whether this lifespan reduction is
due to the apparent progressive muscle weakness and par-
tial paralysis seen or to a direct effect on known ageing
pathways [43-45].
Pharyngeal pumping rate defect
Since the Unc and Egl phenotypes of nfi-1 mutant worms
could reflect aberrant muscle function, we examined
another process that can influenced by muscle defects,
pharyngeal pumping rate. Pharyngeal pumping rates are
reduced in nfi-1 mutant worms (Table 1, Days 1–4), with
more severe reductions in older vs. younger adult animals
(Table 1, Days 3&4 vs. Day 1).
Rescue of nfi-1 mutant with nfi-1 transgene
Transgenic rescue was performed to test whether loss of
the nfi-1 gene was responsible for the observed pheno-
types. Transgenic strain XA512 qaEx507 was made by
injecting a plasmid containing a 10 kb region of genomic
DNA including the nfi-1 coding region and ~4 kb of
upstream promoter region together with a rol-6(gf)
expressing plasmid into the gonads of N2 worms. We
crossed the resulting transgenic array into nfi-1 mutant
worms to produce strain XA550 nfi-1(qa524) qaEx507.
Egg-laying was completely rescued in nfi-1 qaEx507
worms when compared to the nfi-1 mutant worms (Fig.
6A). In addition, the median life span in nfi-1 qaEx507
worms of 13.0 ± 0.7 days was significantly longer than the
10.0 ± 0.7 day life span of nfi-1 mutant worms (p < 0.05),
but slightly less than the 14.0 ± 0.8 day life span of N2
worms (Fig. 6B). The N2 qaEx507 stain used as a control
has a 14.00 ± 0.49 day median life span, identical to that
in non-transgenic N2 worms. The pharyngeal pumping
defect was also partially rescued by transgenic expression
of nfi-1 (Table 1, nfi-1 qaEx507 vs. nfi-1). The nfi-1 trans-
gene had little or no effect on pumping rates in N2 worms
(N2 qaEx507 vs. N2). These data provide a well-defined
developmental system affected by loss of nfi-1 that can be
examined for cell-autonomous or inductive roles of nfi-1.
The presence of the rol-6 marker gene prevented scoring of
rescue of the locomotion phenotype in nfi-1 qaEx507
worms.Page 6 of 17
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A) Deletion in C. elegans nfi-1 gene. The relative locations of confirmed exons (boxes) are shown. Square brackets indi-
cate the location of the NFI-1 DNA-binding domain and the region deleted in nfi-1 mutant. The arrows indicate the position of 
the Tc1 insertion in an intron of the nfi-1 gene in strain NL747 pk240 and locations of PCR primers used in the screening for 
the deletion. B) Single-worm PCR reactions on N2 worm and nfi-1 homozygous mutant isolated by sib-selection. 
The arrows indicate a 1007 bp and 2969 bp PCR products corresponding to the nfi-1 mutant (qa524) and wild type alleles 
respectively. Lane 2 is 1 kb DNA ladder. C) RT-PCR on N2 worms and nfi-1 homozygous mutants. The arrows indi-
cate a 480 bp and 320 bp RT-PCR products amplified using total RNA obtained from N2 worms (lane 1). nfi-1 mutants show 
loss of nfi-1 transcripts (lane 2). Lane (3) is 100 bp DNA ladder. D) Loss of NFI DNA-binding activity in extracts of nfi-
1 mutants. Nuclear extracts of a mixed population of N2 worms and nfi-1 mutants were prepared and used in a gel mobility 
shift assay with an oligonucleotide (2.6) that contains an NFI-binding site (lanes 3, 5) or the same oligo with a single point muta-
tion that abolishes NFI binding (C2) (lane 4, 6). See Fig. 2A for sequences of oligonucleotides. Extract of nfi-1 mutants show 
loss of NFI DNA-binding activity (lanes 5, 6). Lanes 1 & 2, no extract.Page 7 of 17
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scripts are provided maternally. To test whether maternal
nfi-1 transcripts could rescue the nfi-1 Egl phenotype, nfi-
1 qa524/qa524, nfi-1 qa524/+ and +/+ progeny of hetero-
zygous nfi-1 qa524/+ parents were scored for the egg-lay-
ing defect (Fig. 7). Bagging was seen in 41% of the
resulting nfi-1 qa524/ qa524 worms, in 20.7% of nfi-1
qa524/+ worms but in <3% of +/+ animals. These data
indicate the absence of maternal transcript rescue and
possible haploinsufficiency at the nfi-1 locus. Thus, trans-
genic replacement of nfi-1 yields either partial (pumping
rate and lifespan) or complete (egg-laying) rescue of the
phenotypes seen in the nfi-1 mutant worms whereas
maternal nfi-1 transcripts are insufficient to rescue the egg-
laying defect.
Ce titin expression is reduced in nfi-1 mutant worms
We used cDNA microarrays to identify genes whose
expression is affected by loss of nfi-1. Such genes could be
either direct or indirect targets of nfi-1. Poly A+ RNA was
purified from wild type and nfi-1 mutant synchronized
gravid adults, labeled, and used to probe DNA microar-
rays containing ~17,000 C. elegans genes (Stanford Micro-
array Database). We analyzed RNA from gravid adults
because the phenotype differences between nfi-1 mutant
and wild type animals are clearer in adults than at earlier
stages. The nfi-1 gene was scored as the most down-regu-
lated gene in nfi-1 mutant worms in all experiments (data
not shown). Several dozen genes showed small apparent
reductions or increases in levels (2–3 fold) in mutant
adults (data not shown) but only one gene, C. elegans titin
(Ce titin) showed larger changes.
Ce titin (also known as tag-58, temporarily assigned gene
58) was predicted to be 5.7-fold lower in mutant worms
by microarray analysis. Quantitative PCR confirmed that
Ce titin is reduced 8–11 fold in adult nfi-1mutant worms
(Fig. 8). To date this is the gene that shows the largest
decrease in expression in nfi-1 mutant worms. A search of
the Ce titin gene reveals no overabundance of NFI binding
sites (data not shown). Also, a CeTPro transgene
expressing a translational fusion of GFP to the 5'-end of
the Ce titin gene [46] appears to be expressed at similar
levels in WT and nfi-1 mutant worms (data not shown). It
will be important in future studies to determine whether
Ce titin is a direct or indirect target of nfi-1 and the possi-
ble role of Ce titin in the phenotypes observed.
Expression of nfi-1::GFP reporter transgenes
One limitation of in situ hybridization in C. elegans is that
in older embryos and postembryonic stages it is some-
times not sensitive enough to unambiguously identify
Locomotion in nfi-1 mutantsFigure 5
Locomotion in nfi-1 mutants. Single young adults were spotted in the center of fresh plates and left for 10 min. (A, D) 
Photographs of N2 worms and nfi-1 mutants; (B, E) Track patterns of N2 worms and nfi-1 mutants; (C, F) Track patterns of 
N2 worms and nfi-1 mutants with higher magnification. Note less regular tracks in nfi-1 mutant vs. N2 worms.Page 8 of 17
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in muscle by in situ hybridization, in an effort to develop
a more sensitive assay for nfi-1 expression we constructed
two GFP-reporter transgenes (Fig. 9A). In
Pro1CeNFI::GFP, 4 kb of genomic DNA sequence
upstream of the nfi-1 open reading frame and the
sequence encoding the first four residues of the CeNFI
protein was fused in frame to GFP. In Pro2CeNFI::GFP, the
4 kb promoter region and the sequence encoding the first
94 residues of CeNFI has been fused to GFP. GFP expres-
sion for both transgenes was detected in embryos (Fig.
9B). Faint GFP expression is first detected at the late gas-
trulation stage of embryogenesis (>300 cells) as a diffuse
green glow throughout the embryo. By the comma stage
expression is detected in many cells along the outer edge
of the embryo and expression continues through embryo-
genesis and is detected in L1-L4 larvae in many of the
same cells as in adults. Adult transgenic animals show
GFP expression in muscles, neurons and intestinal cells
(Fig. 9B–I). Among the muscles, fluorescence was strong-
est in the pharynx and head muscles, was observed with
less frequency in other body wall muscles and was seen
occasionally in vulva muscles. Expression was also seen in
two pairs of neurons located near the posterior bulb of the
pharynx, and in several as yet unidentified tail neurons.
Expression patterns in multiple transgenic lines from each
reporter were similar with the exception that
Pro2CeNFI::GFP expression was detected more consist-
ently in head neurons and Pro1CeNFI::GFP was seen with
higher frequency in body-wall muscles. However expres-
sion of both transgenes was mosaic, showing expression
in only subsets of cells and animals in each population.
Since mosaic expression of GFP was seen in transgenic
strains from both arrays, transgenic array Pro1CeNFI::GFP
was integrated by γ-irradiation. However similar mosaic
expression was seen with the integrated array (data not
shown). These data may indicate that additional elements
are needed for stable regulation of nfi-1 expression and
that such elements may be located further downstream in
the nfi-1 genomic sequence.
Discussion
nfi-1 gene structure and DNA binding properties
These data show that nfi-1 is not essential for embryogen-
esis and thus is not essential for DNA replication. How-
ever the multiple defects seen in nfi-1-deficient worms,
abnormal locomotion, pharyngeal pumping and egg-lay-
ing defects, and a reduced lifespan indicate that nfi-1 is
essential for these developmental and behavioral proc-
esses. nfi-1 shares a number of properties with the verte-
brate NFI genes, including alternative splicing (Fig. 1) and
the DNA-binding properties of its protein product CeNFI
(Fig. 2B,C). The alternative splicing seen in nfi-1 is remi-
niscent of the complex splicing pattern seen in the verte-
brate NFI genes [22]. While the relevance of this
alternative splicing in C. elegans is unclear, the finding that
alternatively spliced forms of vertebrate NFIs have differ-
ent transcriptional modulation properties [16,47,48] sug-
gests that the multiple C. elegans isoforms may also have
A) Egg-laying defect in nfi-1 mutants and transgenic rescueFigure 6
A) Egg-laying defect in nfi-1 mutants and transgenic 
rescue. Bagging was measured in wild-type N2, nfi-1, N2 
worms carrying the transgenic array qaEx507(N2 qaEx507) 
and nfi-1 worms carrying this array (nfi-1 qaEx507). Bars rep-
resent % of bagging as the mean of 3–4 independent experi-
ments and error bars show the standard deviation. 30–75 
worms of each genotype were scored in each independent 
experiment. N2 and N2 qaEx507showed <5% bagging. The 
nfi-1 mutant worms showed ~30% bagging while the rescued 
nfi-1 qaEx507showed <5% bagging. B) Shortened life span 
in nfi-1 mutants and transgenic rescue. Survival curves 
for the strains described above N2 (n = 57), nfi-1 (n = 58), 
N2 qaEx507 (n = 52) and nfi-1 qaEx507 (n = 31) are shown. 
Kaplan-Meier analysis (SPSS11 software) was use to deter-
mine median, percentile and p values (log rank test) and 
Excel was used to construct survival curves. The array gener-
ated ~50% rescue of the life-span. The experiment was 
repeated twice with similar results.Page 9 of 17
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mine whether alternatively spliced isoforms of nfi-1 are
differentially expressed in worm cells during development
and in adults. In addition, when specific downstream tar-
gets of nfi-1 are identified it will be important to deter-
mine whether the isoforms differ in their ability to
modulate gene expression in C. elegans.
The sequence conservation of the predicted DNA-binding
domain of nfi-1 with the vertebrate NFI proteins was the
initial indication that nfi-1 encodes the single C. elegans
NFI gene. However among the 4 mouse (and human) NFI
genes, 151 of 190 residues of their DNA-binding domains
are completely conserved, while 60 of these 151 residues
are changed in CeNFI (Fig. 1B). We show that CeNFI
binds to the same DNA sequence as hNFI-C and that
binding is abolished by a point mutation known to abol-
ish binding by products of the 4 vertebrate NFI genes (Fig.
2) [38]. This raises the question of why there has been so
little divergence of the 4 vertebrate NFI DNA-binding
domains during evolution. While we have shown similar
DNA binding specificities of CeNFI and hNFI-C to a
matched set of WT and mutant NFI binding sites, it is pos-
sible that subtle differences exist in their DNA-binding
specificity or affinity or that the conserved vertebrate resi-
dues are more important for binding within the more
Table 1: Rescue of pharyngeal pumping defect by nfi-1 transgene
Daya N2 nfi-1 N2 qaEx507b nfi-1 qaEx507b
1 (n = 10) 241 ± 5 228 ± 9c 243 ± 5 241 ± 8e
2 (n = 12) 242 ± 10 187 ± 64d 237 ± 8 195 ± 78d
3 (n = 12) 214 ± 18 125 ± 79c 183 ± 78 200 ± 72
4 (n = 12) 160 ± 62 92.5 ± 86d 183 ± 79 133 ± 90
a Pharyngeal pumping was counted for one minute starting on day one, when animals first reached adulthood, for four consecutive days.
b N2 and nfi-1 mutant worms were transformed with a transgene containing the nfi-1 gene and upstream promoter and rol-6 (qaEx507).
c This value is statistically significantly different from N2 (P < 0.01)
d This value is statistically significantly different from N2 (P < 0.05)
e This value is statistically significantly different from nfi-1 (P < 0.01)
Haploinsufficiency of nfi-1 locusFigure 7
Haploinsufficiency of nfi-1 locus. Egg-laying defect in 
progeny of nfi-1 heterozygous mutant animals are shown. 
Bagging was scored in all progeny of two nfi-1(qa524/+) het-
erozygous worms (n = 146) derived from eggs laid over 7 
hours. All worms were genotyped by single-worm PCR. Bars 
represent % of bagging in wild type (+/+), nfi-1 heterozygous 
(qa524/+) and nfi-1 homozygous worms (qa524/qa524). The 
number of worms scored of each genotype are shown above 
the bars.
Down regulation of Ce titin expression in nfi-1 mutants assessed by QPCRFigur  8
Down regulation of Ce titin expression in nfi-1 
mutants assessed by QPCR. Bars represent fold changes 
in Ce titin transcript level in wild type N2 vs. nfi-1 mutant 
worms. RNA samples were obtained from 3 independent 
synchronized adult worm populations for each genotype.Page 10 of 17
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Expression pattern of the nfi-1::GFP reporter transgenes. The nfi-1 locus and structure of the nfi-1-GFP fusion con-
structs are shown (A). Nfi-1 coding regions are shown in black, gray boxes indicate alternatively spliced exons, untranslated 
regions are in white. GFP is shown as a hatched box. Expression of nfi-1-GFP reporter constructs was observed in embryos 
(B), intestinal cells (C), body wall muscles (D, E), pharynx (F), egg-laying muscles (G), several head (H) and tail neurons (I). 
Expression was assessed using a FXA Nikon microscope (B-D, F-I) and a Bio-Rad confocal microscope (E).Page 11 of 17
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genes are sometimes expressed in the same cells in vivo
[13], it is possible that there has been selection for conser-
vation of residues involved in DNA binding due to com-
petition between the 4 NFI gene products, and that this
has led to the observed high degree of sequence
conservation. Similar high levels of sequence conserva-
tion are seen in the DNA-binding domains of all the
homologous vertebrate NFI genes from Xenopus [49,50] to
humans [12,51].
It is possible that the additional conserved residues in the
vertebrate NFI DBDs compared to nfi-1 confer additional
functions to the vertebrate NFI proteins, such as interact-
ing with proteins required for transcriptional modulation
specifically in vertebrates, or for the stimulation of Ad
DNA replication. Indeed, 2 sets of mutations in the NFI-C
DBD that abolish Ad replication without affecting DNA-
binding or dimerization are in residues not conserved
between NFI-C and CeNFI [52]. However, each of the 4
cysteine residues shown previously to be essential for
DNA-binding activity and redox-regulation of DNA-bind-
ing activity of vertebrate NFIs are conserved in CeNFI (Fig.
1B, labeled C) [53,54]. The conservation of these cysteine
residues is consistent with our observation that the DNA-
binding activity of CeNFI is sensitive to reversible inacti-
vation by chemical oxidizing agents such as diamide in
vitro (data not shown), as is the activity of the vertebrate
NFIs [53,54]. Given the divergence of the CeNFI and ver-
tebrate NFI DBDs it will be important to determine
whether the nfi-1 DBD can substitute for the vertebrate
NFI DBDs in vivo, and whether the vertebrate NFI DBDs
possess equivalent activities in C. elegans in vivo.
Defects in nfi-1 mutant worms
Deletion of the nfi-1 gene results in a number of behavio-
ral defects, each of which may be related to defects in
muscle or neural function. The C. elegans hermaphrodite
has four major muscles types, body wall, pharyngeal,
vulval and enteric [55]. Body-wall muscles and pharyn-
geal muscles, used in locomotion and pumping food,
respectively, function in the processes affected in nfi-1
mutants. The structures most often affected in Unc
mutants are the body-wall muscles, the nervous system
and the hypodermis [56]. Polarized light microscopy
showed no obvious deformities in the body wall-muscles
of nfi-1 mutant animals, such as defects in muscle attach-
ment and overall sarcomere structure. Thus, the muscles
appear normal at a gross level. Likewise, we analyzed the
expression pattern of the body wall muscle specific hlh-
1::GFP [57] and muscle specific CeTPro transgenes [46] in
the nfi-1 deletion mutant background by confocal micro-
scopy and saw no differences between mutant and wild
type animals (data not shown). Thus any muscle defects
are not due to gross structural changes within the muscle.
Many older nfi-1 deficient animals display egg-laying
defects, suggesting that vulval or/and uterine muscles or
their controlling neurons may be affected. The normal
stimulation of egg-laying by serotonin suggests that there
is no major loss of vulval or uterine muscle function in
young adult nfi-1 deficient worms [58,59]. We have visu-
ally examined the functions of the enteric muscles
involved in food movement through the gut and defeca-
tion and found no obvious defects in young adults. In
older adults, contractions of the enteric muscles were less
regular, but it is unclear whether this is an intrinsic defect
or related to the defects in pharyngeal pumping seen in
older adults.
The absence of obvious muscle defects in nfi-1 null worms
raises the possibility that neural defects could underlie the
phenotypes seen in these animals. For example, nfi-1
mutants show a reduced pharyngeal pumping rate, a proc-
ess regulated primarily by the M3, M4 and MC pharyngeal
neurons [60]. Some or all of defects seen in nfi-1 mutant
worms, mild Unc with flaccidity, pharyngeal pumping
and egg-laying are also seen in worms containing single
mutations in genes expressed in neurons. For example,
some mutations in egl-30, a heterotrimeric Gqα subunit
expressed in muscles and neurons, have weak Unc, egg-
laying and pharyngeal defects [61]. In addition, some loss
of function mutations in the G protein signaling molecule
egl-10 and the Gβ5 ortholog eat-11 cause sluggish move-
ment, egg-laying, and pharyngeal pumping defects
[62,63]. Since a number of eat genes are expressed
specifically in neurons, these data indicate that neural dys-
function caused by loss of nfi-1 could generate this range
of phenotypes. It will be important in future studies to
determine whether nfi-1 expression is needed neurons,
muscles, both cell types or other cell types to alleviate the
phenotypes seen in nfi-1 mutant worms. While our pre-
liminary QPCR data indicate no changes in the transcript
levels of egl-30, egl-10 or eat-11 (N. Butz, unpublished
data), it is possible that the activity of the G protein sign-
aling system is affected in nfi-1 mutant worms. Thus, it
would be useful in future studies to directly test whether
nfi-1 is involved in G protein signaling in C. elegans.
The only gene whose expression has been shown to
change in response to loss of nfi-1 is the muscle-specific
gene Ce titin. This reduction in a muscle-specific gene
indicates that muscle defects could contribute to the
observed locomotion and other phenotypes. Ce titin is a
massive protein, with isoforms in C. elegans of 2.2MDa,
1.2MDa and 301KDa [46]. Ce titin is found in the I-bands
of larval and adult muscle in worms. Mutations in mouse
titin genes cause muscular dystrophy [64], cardiac devel-
opment defects and muscle weakness [65]. Thus, down
regulation of Ce titin expression could contribute to the
motility and egg-laying defects observed in nfi-1 mutants.Page 12 of 17
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ficult to generate transgenic lines that conditionally
express Ce titin. Recent studies have reported that neither
existing mutations in Ce titin, nor RNAi experiments,
have provided clues as to the function of Ce titin in worms
[46]. Thus it will be important in the future to test directly
the role of Ce titin in the defects seen in nfi-1 mutant
worms.
Finally, it is unknown whether the observed motility, egg-
laying and pharyngeal pumping defects contribute to the
shortened life-span of nfi-1 null worms. For example, as
pharyngeal pumping becomes more defective the animals
could starve, leading to progressive muscle wasting, paral-
ysis and death. However, most severe eat mutants have
extended lifespans rather than reduced lifespans, most
likely due to caloric restriction [66]. These data indicate
that the reduced lifespan seen in nfi-1 deficient worms
could be independent from the pharyngeal pumping
defect. In addition, while bagging could reduce apparent
lifespan, we eliminated bagged animals from our lifespan
analysis so as to exclude bagging as a direct cause of the
shortened lifespan. Lastly, the motility defect is seen in
young adults a few days prior to bagging and is seen in all
adults, even those that do not bag. Thus it appears
unlikely that bagging contributes directly to the
movement defect. It will be important to use directed
expression of nfi-1 in different cell types to test the
dependence or independence of the observed phenotypes
from each other. We are also currently testing whether nfi-
1 is part of the genetic pathways known to be important
in worm aging including the daf pathway [67].
Roles of NFI transcription factors in development
Since NFI genes have been found in all metazoa
sequenced to date and multiple NFI genes are present in
complex animals [68], it was our initial hypothesis that
nfi-1 would be essential in worms and that deletion of the
gene would be lethal. Lethality would be predicted if nfi-1
has an essential role in DNA replication. However, all of
the defects observed are late physiological defects and are
most severe in older adults. This set of late defects can be
compared to the late gestational defects seen with dele-
tion of single NFI genes in mice. Disruption of the mouse
Nfia gene causes agenesis of the corpus callosum, the loss
of specific midline glial populations and perinatal
lethality [32,33]. Loss of Nfic produces specific defects in
tooth development including aberrant incisor formation
and failure of root formation in molar teeth [34]. Targeted
insertion into the Nfib locus causes perinatal lethality due
to a failure of late fetal lung maturation [35,36]. One com-
mon feature of the defects seen in NFI-deficient mice is
that they occur either late in fetal development (Nfia and
Nfib), or early in postnatal development (Nfic). While
some of the developmental systems affected by the loss of
NFI genes in mice are not present in worms (e.g. lungs and
teeth), it is possible that the underlying molecular mech-
anisms disrupted in NFI-deficient mice are also affected
by loss of nfi-1 in worms. Thus it will be important to test
genes identified as important in the phenotypes of NFI-
deficient mice for potential roles in the motility, egg-lay-
ing and pharyngeal-pumping defects seen in nfi-1mutant
worms.
Conclusion
These data show that nfi-1 is not essential for worm sur-
vival but plays important roles in locomotion, egg-laying,
pharyngeal pumping and maintenance of a normal life-
span. These are the first data to show that while NFI
proteins are essential for adenovirus DNA replication,
they are not essential for DNA replication in simple
animals.
We show that while many residues of the DNA binding
domain of worm NFI differ from those found in verte-
brate NFIs, the DNA binding activity and specificity of the
worm protein is indistinguishable from that of the
vertebrate NFIs. These data suggest that the very strong
conservation of many residues in the DNA-binding
domains of vertebrate NFIs is not needed for DNA-bind-
ing specificity but may serve another function, perhaps for
interactions with specific vertebrate proteins. In addition,
like the vertebrate NFI genes nfi-1 is alternatively spliced,
raising the possibility that different CeNFI isoforms may
have different biological functions.
The phenotypes of nfi-1 null worms are rescued by zygotic
expression of nfi-1 from its natural promoter but not by
maternal transcripts. We propose that nfi-1 regulates gene
expression directly in cells in which it is expressed and
affect the function of these cells. However, the precise cell
types in which loss of nfi-1 causes these defects in motility,
egg-laying, pharyngeal pumping and lifespan is
unknown. Directed expression of nfi-1 in different cells of
the worm should allow us to determine in which cells nfi-
1 is needed for normal lifespan, motility, egg-laying and
pharyngeal pumping.
Future studies will assess whether C. elegans can be used as
an experimental system to assess the potentially distinct
physiological functions of the vertebrate NFI gene prod-
ucts. For example, if the 4 vertebrate NFI genes have segre-
gated the functions of the single worm nfi-1 gene into 4
distinct entities, then each vertebrate NFI gene might have
distinct properties when expressed in nfi-1mutant worms.
It will also be important to determine the specific nfi-1 tar-
get genes in C. elegans whose altered expression is respon-
sible for the phenotypes observed, the specific cell types in
which nfi-1 must be expressed to prevent each phenotype,Page 13 of 17
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NFI-regulated transcription.
Methods
Strains and transgene plasmids
The Bristol strain N2 was used as wild type and worms
were grown at 20°C using standard techniques [69].
Strains containing hlh-1:GFP, CeTPro and NL747 pk240
were kindly provided by Michael Krause (NIH/NIDDK/
LMB, Bethesda, MD), Guy M. Benian (Emory University
School of Medicine, Atlanta, GA) and Ronald Plasterk
(Hubrecht Laboratory, Utrecht, The Netherlands),
respectively.
For rescue experiments the nfi-1 locus from cosmid
ZK1290 was cloned into pBluescriptKS+ to generate
pCeNFIG. pCeNFIG (25 ng/ul) was injected in N2 wild
type worms along with the rol-6(gf) marker plasmid pRF4
(125 ng/ul) using standard microinjection procedures to
produce the transgenic strain XA512 qaEx507 [69]. Trans-
genic arrays were crossed onto the nfi-1 deletion strain
(XA549 nfi-1(qa524), see below) screening F1 and F2
progeny by PCR for the wild-type and nfi-1(qa524) dele-
tion alleles.
Two GFP-reporter constructs were made to assess nfi-1
expression. Pro1CeNFI::GFP was made by cloning a PCR-
generated HindIII-XmaI fragment of ZK1290 into
pPD95.69 (kindly provided by A. Fire) to generate a trans-
lational fusion of nfi-1 and GFP. The 5'end of the con-
struct was extended by cloning the HindIII-BglII fragment
of pCeNFIG into the vector. Pro2CeNFI::GFP was made by
cloning a HindIII-PstI fragment of pCeNFIG into corre-
sponding sites of pPD95.69. The constructs were
coinjected with rol-6 marker into N2 worms as described
above. Three independent transgenic lines were analyzed
for Pro1CeNFI::GFP expression and two lines for
Pro2CeNFI::GFP expression.
A vector expressing the 6his-tagged DNA-binding domain
of CeNFI (pCeNFI-H6) in E. coli was produced by cloning
a fragment of nfi-1 cDNA encompassing the predicted
DNA-binding domain of nfi-1 downstream of a 6 histi-
dine tag into the pET8C vector [70].
Generation of the nfi-1 deletion mutant
C. elegans NL747 pk240 contains a Tc1 transposon inser-
tion in the 6 th intron of nfi-1. The location of the Tc1 ele-
ment was mapped by genomic PCR and sequencing. 100
populations of worms were established at 15°C on 3 cm
NGM/OP-50 plates starting with 10–20 worms each, and
the worms were collected in M9 buffer when nearing star-
vation. One third of the worms were put onto fresh plates
and the rest were used to prepare two separate lysates for
DNA. Thirteen of the 100 populations showed a strong
excision bands by PCR screening (Platinum Taq Polymer-
ase, Invitrogen) with primers 1 (5'GTATTTGTACGAC-
CCTCTGCG) and 2 (5'TGCTGTTGAACGGAATGCACC).
To distinguish between germ line and somatic mutations
the second lysate for each positive population was
screened by PCR. Only two populations showed deletions
with both lysates indicating that more than one worm car-
ried the deletion and therefore the deletions were in the
germ line. The locations of the deletions were determined
by subcloning PCR products into pCRII-TOPO (Invitro-
gen) and sequencing. A clonal strain of worms carrying
one of these deletions was isolated by multiple rounds of
PCR screening and sib-selection (strain XA549 nfi-
1(qa524)). The mutant worms were backcrossed 12 times
onto the wild-type N2 strain to remove unwanted muta-
tions. For genotyping, PCR with primers 1 and 3 (5'TCG-
GAGGAGGTGGTAGACAT) amplified a 623 bp product
from the deletion allele and primers 1 and 4
(5'GTGAGTCTTGAGGTGCTTCTG) amplified a 968 bp
product from the wild type allele.
RT-PCR cloning and cDNA isolation
Total RNA was prepared from adult worms or eggs (Trizol,
Life Technologies) and was reverse transcribed using oligo
dT (Superscript, Life Technologies) according to the
manufacturers instructions. Poly A+ mRNA was isolated
from total RNA using standard techniques (Oligotex, Qia-
gen). PCR was performed as described previously [14]
using primers from within predicted exons 1–14 of nfi-1
or SL1 primers (GGTTTAATTACCCAAGTTTGAG) (nfi-1
primer sequences available upon request) and PCR prod-
ucts were cloned into the pCRII-TOPO vector (Invitro-
gen). DNA from individual clones was isolated (Wizard,
Promega) and sequenced (Roswell Park Cancer Institute
DNA Sequencing Core) and the sequence obtained com-
pared with that of the predicted exons of nfi-1 (C. elegans
cosmid ZK1290, Genbank Acc. #U21308). The cDNA
clones yk42f10 and yk213C10 were from the C. elegans
cDNA sequencing/expression project (CREST and Gene
Network Lab, National Institute of Genetics, Mishima)
and CEESQ09 was from The Institute for Genomic
Research (TIGR).
In situ hybridization
Endogenous nfi-1 transcripts were analyzed as described
previously [39], using digoxin-labeled antisense probe for
nfi-1. Embryos were either freeze-fractured or were treated
with chitinase to digest the eggshell prior to
hybridization.
DNA-binding assays
Electrophoretic mobility shift assays for the analysis of
NFI protein binding to oligonucleotides was performed as
described previously [38,54]. Worm extracts were pre-
pared from dounce homogenized mixed-age worms usingPage 14 of 17
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[38]. CeNFI-H6 (332aa) and hNFI-C220-H6 (230aa) pro-
teins were produced and partially purified from extracts of
E. coli as described previously [54]. The labeled oligonu-
cleotides used contained a wild-type NFI binding site
(2.6) or a site with a single point mutation (C2) shown
previously to abolish the binding of vertebrate NFI pro-
teins [19,38,54,71].
Behavioral and functional assays
For locomotion assays wild type N2 and nfi-1 mutants
were raised at 20°C on NGM/OP50 plates. To obtain age-
synchronized worms young adults were placed on a bac-
terial lawn to allow them to lay eggs for 3 hours and then
removed. Worms were observed at all larval stages. To
photograph worms tracks, single young adult worms were
moved to new plates containing a 1 day old bacterial lawn
and were left undisturbed for 10 min.
"Bag of worms" phenotype was scored for each strain
using age-synchronized worms. Worms were observed
each day from the start of egg laying until one day after
cessation of egg laying. They were moved to new plates
every second day to prevent overcrowding and starvation.
Other aspects of egg-laying behavior such as the brood
size, stage of newly laid eggs, and response to serotonin
were assessed as described previously [58,59]. Brood size
was the same in WT and nfi-1 null worms.
For life-span assays wild type N2 and nfi-1 mutants were
raised and synchronized as described above except that
250 µg/ml of fungizone was included to reduce fungal
contamination. Worms were maintained at 20°C and
adult worms were moved to new plates every second day
until progeny production ceased. Worms were observed
every day and were scored as dead when they failed to
respond to touch. Animals that crawled off the plate or
died from internally hatched progeny were censored, but
incorporated into the data until the day of
disqualification.
Pharyngeal pumping was counted for one minute starting
on the first day of adulthood for four consecutive days
[60]. Worms were placed on NGM/OP50 plates and left
undisturbed for 1 hour before measuring. All animals
remained on food during the period of observation.
Microarray assays and QPCR
Synchronized populations were generated by hatching
eggs after alkaline hypochlorite-treatment and the worms
were collected as gravid adults. Total RNA was prepared
with Trizol (Life Techologies) and poly A RNA was puri-
fied using Poly(A)Purist™ kit (Ambion). DNA microarray
assays were performed and analyzed in the Stanford
Microarray Database (Stanford). cDNA for QPCR was
made using random primers and Super-Script (Invitro-
gen). QPCR was performed using AmpliTaq GoldR with
the Gene AmpR SYBR green kit (Applied Biosystems) on a
Bio-Rad iCycler. The inf-1 gene was used as an internal
control for RT-PCR reactions and for normalized quantifi-
cation in QPCR reactions. Primers used in QPCR are avail-
able on request.
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